Salarius Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLRX and other ETFs, options, and stocks.About SLRX
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor.
CEOFrederick E. Pierce
CEOFrederick E. Pierce
Employees2
Employees2
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2014
Founded2014
Employees2
Employees2
SLRX Key Statistics
Market cap4.61M
Market cap4.61M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume333.17K
Average volume333.17K
High today$0.8255
High today$0.8255
Low today$0.78
Low today$0.78
Open price$0.8002
Open price$0.8002
Volume129.48K
Volume129.48K
52 Week high$108.00
52 Week high$108.00
52 Week low$0.7106
52 Week low$0.7106
Stock Snapshot
Salarius Pharmaceuticals(SLRX) stock is priced at $0.78, giving the company a market capitalization of 4.61M. It carries a P/E multiple of -0.02.
As of 2025-12-13, Salarius Pharmaceuticals(SLRX) stock has fluctuated between $0.78 and $0.83. The current price stands at $0.78, placing the stock 0.0% above today's low and -5.5% off the high.
Salarius Pharmaceuticals(SLRX) shares are trading with a volume of 129.48K, against a daily average of 333.17K.
During the past year, Salarius Pharmaceuticals(SLRX) stock moved between $0.71 at its lowest and $108.00 at its peak.
During the past year, Salarius Pharmaceuticals(SLRX) stock moved between $0.71 at its lowest and $108.00 at its peak.
People also own
Based on the portfolios of people who own SLRX. This list is generated using Robinhood data, and it’s not a recommendation.